Scientists probe hidden heart dangers of modern cancer pills

NCT ID NCT07174141

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Universitaire Dijon Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how often newer cancer drugs cause heart rhythm problems or high blood pressure. Researchers will closely monitor 100 patients taking these medications for one year to identify which patients are most at risk. The goal is to help doctors provide better, safer care by predicting these side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TREATMENT WITH SECOND-GENERATION BRUTON'S TYROSINE KINASE INHIBITORS (ACALABRUTINIB, ZANUBRUTINIB) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU Dijon Bourgogne
RECRUITING

Dijon, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

TREATMENT WITH SECOND-GENERATION BRUTON'S TYROSINE KINASE INHIBITORS (ACALABRUTINIB, ZANUBRUTINIB)